These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 18281374)

  • 1. Diabetes and vessel wall remodelling: from mechanistic insights to regenerative therapies.
    Spinetti G; Kraenkel N; Emanueli C; Madeddu P
    Cardiovasc Res; 2008 May; 78(2):265-73. PubMed ID: 18281374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial loss and repair in the vascular complications of diabetes: pathogenetic mechanisms and therapeutic implications.
    Gilbert RE
    Circ J; 2013; 77(4):849-56. PubMed ID: 23503045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation.
    Tongers J; Roncalli JG; Losordo DW
    Microvasc Res; 2010 May; 79(3):200-6. PubMed ID: 20144623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise.
    Keats EC; Khan ZA
    Cardiovasc Diabetol; 2012 Apr; 11():37. PubMed ID: 22524626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endoplasmic reticulum stress signalling in diabetic endothelial dysfunction and atherosclerosis.
    Dong Y; Fernandes C; Liu Y; Wu Y; Wu H; Brophy ML; Deng L; Song K; Wen A; Wong S; Yan D; Towner R; Chen H
    Diab Vasc Dis Res; 2017 Jan; 14(1):14-23. PubMed ID: 27941052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of endothelial progenitor cells in subjects with diabetes.
    Fadini GP; Sartore S; Agostini C; Avogaro A
    Diabetes Care; 2007 May; 30(5):1305-13. PubMed ID: 17277037
    [No Abstract]   [Full Text] [Related]  

  • 7. Regenerative therapies for diabetic microangiopathy.
    Bassi R; Trevisani A; Tezza S; Ben Nasr M; Gatti F; Vergani A; Farina A; Fiorina P
    Exp Diabetes Res; 2012; 2012():916560. PubMed ID: 22536216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
    Lunder M; Janić M; Šabovič M
    Curr Vasc Pharmacol; 2019; 17(1):6-15. PubMed ID: 29412116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial progenitor cells for the treatment of diabetic vasculopathy: panacea or Pandora's box?
    Liew A; McDermott JH; Barry F; O'Brien T
    Diabetes Obes Metab; 2008 May; 10(5):353-66. PubMed ID: 17825082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of angiopathy in diabetes.
    Skrha J
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S324-9. PubMed ID: 14704862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium.
    Ding H; Triggle CR
    Vasc Health Risk Manag; 2005; 1(1):55-71. PubMed ID: 17319098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in vascular repair by endothelial progenitor cells in diabetic patients.
    António N; Fernandes R; Ribeiro CF; Providência LA
    Cardiovasc Hematol Disord Drug Targets; 2010 Sep; 10(3):161-6. PubMed ID: 20678063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 diabetic Lepr(db/db) mice show a defective microvascular phenotype under basal conditions and an impaired response to angiogenesis gene therapy in the setting of limb ischemia.
    Emanueli C; Caporali A; Krankel N; Cristofaro B; Van Linthout S; Madeddu P
    Front Biosci; 2007 Jan; 12():2003-12. PubMed ID: 17127438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic peptides improve blood flow and promote capillary growth in a diabetic and ischaemic mouse model.
    Raiter A; Bechor Z; Kleiman M; Leshem-Lev D; Battler A; Hardy B
    Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):381-8. PubMed ID: 20226697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise of EPC-based therapies on vascular dysfunction in diabetes.
    Georgescu A; Alexandru N; Constantinescu A; Titorencu I; Popov D
    Eur J Pharmacol; 2011 Nov; 669(1-3):1-6. PubMed ID: 21839073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications.
    Yang DR; Wang MY; Zhang CL; Wang Y
    Front Endocrinol (Lausanne); 2024; 15():1359255. PubMed ID: 38645427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration.
    Fadini GP; Ferraro F; Quaini F; Asahara T; Madeddu P
    Stem Cells Transl Med; 2014 Aug; 3(8):949-57. PubMed ID: 24944206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries.
    Kahlberg N; Qin CX; Anthonisz J; Jap E; Ng HH; Jelinic M; Parry LJ; Kemp-Harper BK; Ritchie RH; Leo CH
    Pharmacol Res; 2016 Sep; 111():325-335. PubMed ID: 27363948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of reendothelialization after arterial injury.
    Versari D; Lerman LO; Lerman A
    Curr Pharm Des; 2007; 13(17):1811-24. PubMed ID: 17584110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endothelium in the pathogenesis of diabetic microangiopathy.
    La Selva M; Beltramo E; Passera P; Porta M; Molinatti GM
    Acta Diabetol; 1993; 30(4):190-200. PubMed ID: 8180411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.